Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers The Lead Compound

Home › Targets › IL-18

IL-18 (1 companies · 2 programs)

Companies with an active program directed at IL-18.

Evommune, Inc. EVMN

EVO301 — Atopic Dermatitis Phase 2
EVO301 — Ulcerative Colitis

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.